EP Patent

EP1302200A1 — Pharmaceutical formulation of a budesonide-containing water-propylene glycol solution and method of preparing it

Assigned to Italchimici SpA · Expires 2003-04-16 · 23y expired

What this patent protects

A pharmaceutical formulation of a budesonide-containing water-propylene glycol solution is composed of budesonide, as an active substance, in a concentration between 0.05 and 0.1%, a stabilizer of sodium chloride, citric acid and sodium citrate, in an amount between 0.005 and 0.5…

USPTO Abstract

A pharmaceutical formulation of a budesonide-containing water-propylene glycol solution is composed of budesonide, as an active substance, in a concentration between 0.05 and 0.1%, a stabilizer of sodium chloride, citric acid and sodium citrate, in an amount between 0.005 and 0.5%, and a solvent of polypropylene glycol and water, in the required amount to achieve 100% of a finished solution. A method of preparing such a solution is also described.

Drugs covered by this patent

Patent Metadata

Patent number
EP1302200A1
Jurisdiction
EP
Classification
—
Expires
2003-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Italchimici SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.